Search research articles
Contact Us
Filters
Showing results (101-110 of 153) with videos related to
Page
of 16
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
December 16, 2024
The mouth of America: the oral microbiome profile of the US population
Anil K Chaturvedi, Emily Vogtmann, Jianxin Shi, et al.
The Journal of Infectious Diseases
|
June 13, 2025
The oral microbiome and all-cause mortality in aUS population representative prospective cohort
Emily Vogtmann, Yukiko Yano, Jianxin Shi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 7, 2023
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
Anil K Chaturvedi, Eric A Engels, Ruth M Pfeiffer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 16, 2024
Human Papilloma Virus Circulating Cell-Free DNA Kinetics in Patients with Cervical Cancer Undergoing Definitive Chemoradiation
Aaron Seo, Weihong Xiao, Olsi Gjyshi, et al.
Journal of Virology
|
May 25, 2012
The fanconi anemia pathway limits human papillomavirus replication
Elizabeth E Hoskins, Richard J Morreale, Stephen P Werner, et al.
Cancer Causes & Control : CCC
|
November 3, 2016
The association of medication use with clearance or persistence of oral HPV infection
Jennifer O Lam, Elizabeth A Sugar, Ross D Cranston, et al.
The Oncologist
|
May 31, 2022
Long-term Outcomes with Nivolumab as First-line Treatment in Recurrent or Metastatic Head and Neck Cancer: Subgroup Analysis of CheckMate 141
Maura L Gillison, George Blumenschein, Jerome Fayette, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 26, 2021
Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311)
Robert L Ferris, Yael Flamand, Gregory S Weinstein, et al.
The Oncologist
|
June 6, 2018
CheckMate 141: 1-Year Update and Subgroup Analysis of Nivolumab as First-Line Therapy in Patients with Recurrent/Metastatic Head and Neck Cancer
Maura L Gillison, George Blumenschein, Jerome Fayette, et al.
Head & Neck
|
February 1, 2021
Cytotoxic and targeted systemic therapy in patients with advanced cutaneous squamous cell carcinoma in the head and neck
Samantha Tam, Mona Gajera, Xiaoning Luo, et al.
Page
of 16
Search research articles
Search
Showing results (101-110 of 153) with videos related to
Sort By:
Page
of 16
Medrxiv : the Preprint Server for Health Sciences
|
December 16, 2024
The mouth of America: the oral microbiome profile of the US population
Anil K Chaturvedi, Emily Vogtmann, Jianxin Shi, et al.
The Journal of Infectious Diseases
|
June 13, 2025
The oral microbiome and all-cause mortality in aUS population representative prospective cohort
Emily Vogtmann, Yukiko Yano, Jianxin Shi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 7, 2023
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
Anil K Chaturvedi, Eric A Engels, Ruth M Pfeiffer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 16, 2024
Human Papilloma Virus Circulating Cell-Free DNA Kinetics in Patients with Cervical Cancer Undergoing Definitive Chemoradiation
Aaron Seo, Weihong Xiao, Olsi Gjyshi, et al.
Journal of Virology
|
May 25, 2012
The fanconi anemia pathway limits human papillomavirus replication
Elizabeth E Hoskins, Richard J Morreale, Stephen P Werner, et al.
Cancer Causes & Control : CCC
|
November 3, 2016
The association of medication use with clearance or persistence of oral HPV infection
Jennifer O Lam, Elizabeth A Sugar, Ross D Cranston, et al.
The Oncologist
|
May 31, 2022
Long-term Outcomes with Nivolumab as First-line Treatment in Recurrent or Metastatic Head and Neck Cancer: Subgroup Analysis of CheckMate 141
Maura L Gillison, George Blumenschein, Jerome Fayette, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 26, 2021
Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311)
Robert L Ferris, Yael Flamand, Gregory S Weinstein, et al.
The Oncologist
|
June 6, 2018
CheckMate 141: 1-Year Update and Subgroup Analysis of Nivolumab as First-Line Therapy in Patients with Recurrent/Metastatic Head and Neck Cancer
Maura L Gillison, George Blumenschein, Jerome Fayette, et al.
Head & Neck
|
February 1, 2021
Cytotoxic and targeted systemic therapy in patients with advanced cutaneous squamous cell carcinoma in the head and neck
Samantha Tam, Mona Gajera, Xiaoning Luo, et al.
Page
of 16